Agenus Inc AGEN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
13.11quote price arrow up+0.04 (+0.31%)
Volume
7,809
Close
13.07quote price arrow up+0.55 (+4.39%)
Volume
635,400
52 week range
4.78 - 42.60
Loading...
  • Open12.75
  • Day High13.58
  • Day Low12.55
  • Prev Close12.52
  • 52 Week High42.60
  • 52 Week High Date06/09/23
  • 52 Week Low4.78
  • 52 Week Low Date04/18/24

Key Stats

  • Market Cap265.122M
  • Shares Out20.28M
  • 10 Day Average Volume1.56M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change-21.07

KEY STATS

  • Open12.75
  • Day High13.58
  • Day Low12.55
  • Prev Close12.52
  • 52 Week High42.60
  • 52 Week High Date06/09/23
  • 52 Week Low4.78
  • 52 Week Low Date04/18/24
  • Market Cap265.122M
  • Shares Out20.28M
  • 10 Day Average Volume1.56M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change-21.07

RATIOS/PROFITABILITY

  • EPS (TTM)-14.04
  • P/E (TTM)-0.93
  • Fwd P/E (NTM)-1.62
  • EBITDA (TTM)-146.517M
  • ROE (TTM)-2,000.13%
  • Revenue (TTM)156.313M
  • Gross Margin (TTM)98.01%
  • Net Margin (TTM)-164.69%
  • Debt To Equity (MRQ)-8.05%

EVENTS

  • Earnings Date05/07/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Agenus Inc

 

Profile

MORE
Agenus Inc. is an immuno-oncology (I-O) company targeting cancer and infectious diseases with a pipeline of immunological agents. It is specialized in developing therapies to activate the body's immune system against cancer and infections. Its pipeline includes immune-modulatory antibodies, adoptive cell therapies (via MiNK Therapeutics, Inc.), and vaccine adjuvants (via SaponiQx, Inc.). Its primary focus is I-O, and its diverse pipeline is supported by its in-house...
Garo Armen Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Christine Klaskin
Vice President - Finance
Address
3 Forbes Rd
Lexington, MA
02421-7305
United States

Top Peers

SYMBOLLASTCHG%CHG
STRO
Sutro Biopharma Inc
3.83-0.11-2.79%
XERS
Xeris Biopharma Holdings Inc
1.89+0.03+1.61%
KPTI
Karyopharm Therapeutics Inc
1.13+0.05+4.63%
FGEN
FibroGen Inc
1.14+0.01+0.88%
SGMO
Sangamo Therapeutics Inc
0.5558+0.0338+6.4751%